Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Blocking interferon-gamma might help treat various autoimmune diseases.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Traditional Persian medicine helped a woman with resistant hyperthyroidism improve and stabilize her condition.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

People from iodine-deficient areas are more likely to develop hypothyroidism when treated for multi-drug resistant tuberculosis.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The sensor accurately measures thallium ions in solutions with high selectivity.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

New micelle nanocarriers deliver Tacrolimus more effectively to skin layers for psoriasis treatment than the current Protopic ointment.

Gamma/delta T cells help defend skin against heavy metals.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.